Study reveals new protein to treat obesity

A recent medical study, carried out by scientists at the Scorsairs Research Institute and cooperating institutions, revealed a major regulator for the development of fat cells, which may provide the use of obesity and diabetes drugs.

Scientists have discovered a protein called TLE3, which plays a dual role, triggering signals that stimulate the formation of fat cells and also stop those signals, working with the protein, which is already the target of several diabetes drugs.

"Our goal is to understand how typical fat cells are formed so that we can develop better treatments for obesity and related disorders," said Professor Enrique Saiz of the Scorbis Research Institute, who led the study with Dr. Peter of the Howard Hughes Medical Institute at the University of California and published by Medical News.

He adds: "Fats are both good and evil, in today's fat culture has a bad reputation due to the accumulation of fat from the diet in liver and muscle tissue, for example, where they cause damage, and on the other hand fatty tissue also produces hormones that help to control the Insulin is weighed in the blood and regulate sepsis production and energy consumption, but in certain conditions such as obesity fatty tissue becomes not working as it should, and when we have a lot of fat they tend to become dysfunctional function, and this is clearly shown in the face of problems such as insulin resistance and diabetes.'

The fat cells, like all cells in the body, are created by stem cells, which are carried out through the paths of one traffic signal from one molecule to another, and when the percentage of fat in the body exceeds the ppary that stimulates the formation of more fat cells to deal with them.